PERSISTENCE TO DENOSUMAB IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AT INCREASED FRACTURE RISK TREATED IN ROUTINE CLINICAL PRACTICE IN BULGARIA

被引：0
|
作者：
Monov, S. [1 ]
Nestorova, R. [2 ]
Velkova, M. [3 ]
Temelkova, N. [4 ]
Jeleva, S. [5 ]
Petkova, R. [6 ]
Petranova, T. [1 ]
机构：
[1] Med Univ, Clin Rheumatol, Sofia, Bulgaria
[2] ASIMP RC St Irina, Sofia, Bulgaria
[3] ASIMP Rheumatol, Russe, Bulgaria
[4] Univ Hosp Alexandrovska, Sofia, Bulgaria
[5] Med Ctr Orfey, St Zagora, Bulgaria
[6] Amgen Bulgaria, Sofia, Bulgaria
来源：
OSTEOPOROSIS INTERNATIONAL | 2020年 / 31卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P856
引用
收藏
页码：S442 / S443
页数：2
相关论文
共 50 条
  • [31] Clinical and nonvertebral fracture risk is reduced with the use of ibandronate in women with postmenopausal osteoporosis
    Miller, P. D.
    Harris, S. T.
    Blumentals, W. A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S451 - S451
  • [32] Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?
    Watts, N. B.
    Roux, C.
    Modlin, J. F.
    Brown, J. P.
    Daniels, A.
    Jackson, S.
    Smith, S.
    Zack, D. J.
    Zhou, L.
    Grauer, A.
    Ferrari, S.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (01) : 327 - 337
  • [33] Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
    Miller, P. D.
    Pannacciulli, N.
    Brown, J. P.
    Czerwinski, E.
    Nedergaard, B. S.
    Bolognese, M. A.
    Malouf, J.
    Bone, H. G.
    Reginster, J. -Y.
    Singer, A.
    Wang, C.
    Wagman, R. B.
    Cummings, S. R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (08): : 3163 - 3170
  • [34] Increased bone turnover, and osteoporosis risk assessment in postmenopausal women: The clinical application
    Mohammed, RR
    Rabou, IBA
    Mohammed, EA
    El Ghobarey, AF
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 507 - 508
  • [35] Osteoporosis Therapy in Postmenopausal Women With High Risk of Fracture
    Cappola, Anne R.
    Shoback, Dolores M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (07): : 715 - 716
  • [36] Determinants of imminent fracture risk in postmenopausal women with osteoporosis
    Barron, R. L.
    Oster, G.
    Grauer, A.
    Crittenden, D. B.
    Weycker, D.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (11) : 2103 - 2111
  • [37] Determinants of imminent fracture risk in postmenopausal women with osteoporosis
    R. L. Barron
    G. Oster
    A. Grauer
    D. B. Crittenden
    D. Weycker
    Osteoporosis International, 2020, 31 : 2103 - 2111
  • [38] Bazedoxifene reduces the risk of fracture in women with postmenopausal osteoporosis
    Nature Clinical Practice Rheumatology, 2008, 4 (11): : 566 - 566
  • [39] Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink
    J. Morley
    A. Moayyeri
    L. Ali
    A. Taylor
    M. Feudjo-Tepie
    L. Hamilton
    J. Bayly
    Osteoporosis International, 2020, 31 : 533 - 545
  • [40] Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink
    Morley, J.
    Moayyeri, A.
    Ali, L.
    Taylor, A.
    Feudjo-Tepie, M.
    Hamilton, L.
    Bayly, J.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (03) : 533 - 545
12345